Cosmos Health Inc. (COSM)

Nov 11, 2026

Cosmos Health Inc. announced its U.S. direct-to-consumer subscription business achieved a monthly subscription value of $1.83 million as of October 31, 2026, equating to approximately $22.0 million on an annualized basis. The company reported 12,532 active U.S. subscriptions and total U.S. e-commerce sales of $1.67 million for October, with 61% from subscriptions. Cosmos Health plans to increase its marketing budget and expand its product offerings through the fourth quarter of 2026.

Nov 11, 2026

Cosmos Health Inc. announced that its U.S. direct-to-consumer subscription business achieved a monthly subscription value of $1.83 million as of October 31, 2026, equating to approximately $22.0 million on an annualized basis. The company reported $1.67 million in total U.S. e-commerce sales for October, with 61% from subscriptions, and plans to continue scaling its direct-to-consumer sales through increased marketing and product expansion in Q4 2026. This growth reflects continued momentum from the mid-September scaling of its subscription model, aiming to build a valuable recurring revenue base.

Nov 9, 2026

Cosmos Health Inc. announced strong growth in its Amazon UK business, with trailing twelve-month (TTM) sales reaching $2.27 million, a 90% increase, and a 23% net profit margin. The company expects this growth to continue, projecting sales of approximately $3.9 million over the next twelve months, representing a 72% increase. This performance highlights the efficiency and profitability of its online sales channel as part of its transition to a high-margin business model.

Nov 5, 2026

Cosmos Health's pharmaceutical distribution subsidiary, CosmoFarm S.A., is commissioning new automated order-processing and vehicle-loading infrastructure at its distribution center in Athens. This investment is expected to significantly reduce processing and loading times, allowing vehicles to depart sooner and handle more pharmacy deliveries. The company believes this automation, along with ongoing acquisitions, will enable CosmoFarm to support over $120 million in annual revenue.

Oct 29, 2026

Cosmos Health Inc. announced a significant surge in its U.S. direct-to-consumer subscription business, with active subscriptions surpassing 12,000 as of October 28, 2026, marking a 92% increase in two weeks. The monthly subscription value also rose by 94% to nearly $1.8 million, and online checkout orders increased by 90%. This growth highlights the success of the company's recurring revenue model, which is now being expanded to Australia, New Zealand, and the broader Oceania region.

Oct 28, 2026

Noble Capital Markets has initiated equity research coverage on Cosmos Health Inc. (NASDAQ: COSM) with an Outperform rating and a price target of $1.40 per share, implying a significant upside of approximately 493% from its recent closing price. The valuation is based on 1.42 times Noble's 2027 revenue estimate, at a discount to peers. Noble forecasts strong revenue growth and positive adjusted EBITDA and free cash flow for Cosmos Health in the coming years.